Evidence map›Paper›PMID 39337391›Full record

ArticleInternational journal of molecular sciences2024

Effects of Omega-3 Polyunsaturated Fatty Acids on the Formation of Adipokines, Cytokines, and Oxylipins in Retroperitoneal Adipose Tissue of Mice.

Tatjana Wenderoth, Martin Feldotto, Jessica Hernandez, Julia Schäffer, Stephan Leisengang, Fabian Johannes Pflieger, Janne Bredehöft, Konstantin Mayer, Jing X Kang, Jens Bier and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tatjana WenderothInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.
Martin FeldottoInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.
Jessica HernandezInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.
Julia SchäfferInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.
Stephan LeisengangInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0002-9959-0236
Fabian Johannes PfliegerInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.
Janne BredehöftInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.
Konstantin MayerDepartment of Internal Medicine, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0002-6565-2187
Jing X KangLaboratory for Lipid Medicine and Technology, Department of Medicine, Massachusetts General Hospital and Harvard Medical, Charlestown, MA 02129, USA.
Jens BierCardio-Pulmonary Institute, Justus Liebig University, 35392 Giessen, Germany.
Friedrich GrimmingerCardio-Pulmonary Institute, Justus Liebig University, 35392 Giessen, Germany.
Nadine PaßlackSmall Animal Clinic, Internal Medicine and Department of Veterinary Clinical Sciences, Justus Liebig University, 35392 Giessen, Germany.
Christoph RummelInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0001-5457-4390

Funding

EU Joint Programme - Neurodegenerative Disease Research (JPND) SOLID JPND2021-650-233Federal Ministry of Education and Research 01ED2207
6 · The paper itself

Abstract

Oxylipins and specialized pro-resolving lipid mediators (SPMs) derived from polyunsaturated fatty acids (PUFAs) are mediators that coordinate an active process of inflammation resolution. While these mediators have potential as circulating biomarkers for several disease states with inflammatory components, the source of plasma oxylipins/SPMs remains a matter of debate but may involve white adipose tissue (WAT). Here, we aimed to investigate to what extent high or low omega (n)-3 PUFA enrichment affects the production of cytokines and adipokines (RT-PCR), as well as oxylipins/SPMs (liquid chromatography-tandem mass spectrometry) in the WAT of mice during lipopolysaccharide (LPS)-induced systemic inflammation (intraperitoneal injection, 2.5 mg/kg, 24 h). For this purpose, n-3 PUFA genetically enriched mice (FAT-1), which endogenously synthesize n-3 PUFAs, were compared to wild-type mice (WT) and combined with n-3 PUFA-sufficient or deficient diets. LPS-induced systemic inflammation resulted in the decreased expression of most adipokines and interleukin-6 in WAT, whereas the n-3-sufficient diet increased them compared to the deficient diet. The n-6 PUFA arachidonic acid was decreased in WAT of FAT-1 mice, while n-3 derived PUFAs (eicosapentaenoic acid, docosahexaenoic acid) and their metabolites (oxylipins/SPMs) were increased in WAT by genetic and nutritional n-3 enrichment. Several oxylipins/SPMs were increased by LPS treatment in WAT compared to PBS-treated controls in genetically n-3 enriched FAT-1 mice. Overall, we show that WAT may significantly contribute to circulating oxylipin production. Moreover, n-3-sufficient or n-3-deficient diets alter adipokine production. The precise interplay between cytokines, adipokines, and oxylipins remains to be further investigated.

Indexed as

AdipokinesCytokinesFatty Acids, Omega-3OxylipinsAdipose Tissue, WhiteAnimalsInflammationIntra-Abdominal FatLipopolysaccharidesMaleMiceMice, Inbred C57BLAdipokinesCytokinesFatty Acids, Omega-3LipopolysaccharidesOxylipinsadipokinescytokinesFAT-1-micelipopolysacchariden-3-polyunsaturated fatty acidsoxylipinssmall pro-resolving lipid mediatorswhite adipose tissue

Identifiers

PMID39337391
PMCPMC11432517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.